US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jun 25, 2021 (5 years ago)

Xylocaine-MPF with Epinephrine 1:200,000, (Lidocaine HCl and Epinephrine Injection, USP)…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Low out of specification results for epinephrine assay.

What was recalled

Xylocaine-MPF with Epinephrine 1:200,000, (Lidocaine HCl and Epinephrine Injection, USP), 1%, 300 mg/30 mL, (10 mg/mL), 30 mL Single Dose Vial, 25 Vials per Tray, Rx only, Fresenius Kabi USA, LLC, Lake Zurich, IL 60047. Vial NDC 63323-487-07, Tray NDC 63323-487-37

Recalling firm
Fresenius Kabi USA LLC
NDC code
63323-487-07
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0651-2021

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Lidocaine recalls

See all